Syndax Pharmaceuticals Inc (SNDX) — Institutional Holders, Q2 2026
242 institutional investment managers reported a SNDX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.4B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SNDX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MILLENNIUM MANAGEMENTAdded · +1,854,436 sh+$40.5M
- STATE STREETAdded · +1,228,348 sh+$26.9M
- LOOMIS SAYLES & L PNew · +923,624 sh+$20.2M
- GOLDMAN SACHS GROUPAdded · +864,478 sh+$18.9M
- Candriam S.C.A.Added · +770,708 sh+$16.8M
Biggest sellers
- Point72 Asset Management, L.P.Sold out · -1,985,547 sh-$43.4M
- StemPoint CapitalSold out · -1,215,743 sh-$26.6M
- Walleye CapitalTrimmed · -379,337 sh-$8.3M
- CITADEL ADVISORSTrimmed · -372,664 sh-$8.1M
- D. E. ShawTrimmed · -361,942 sh-$7.9M
SNDX 13F holders ranked 1–100 of 242
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | BlackRock#1 · 9,020,006 sh | 9,020,006 | $197.2M | <0.01% | +9.3% |
| 2 | Kynam Capital Management#2 · 8,050,959 sh | 8,050,959 | $176.0M | 9.73% | 0.0% |
| 3 | GOLDMAN SACHS GROUP#3 · 5,861,265 sh | 5,861,265 | $128.1M | 0.01% | +17.3% |
| 4 | STATE STREET#4 · 5,658,424 sh | 5,658,424 | $123.7M | <0.01% | +27.7% |
| 5 | BANK OF AMERICA#5 · 4,045,094 sh | 4,045,094 | $88.4M | <0.01% | -4.8% |
| 6 | VANGUARD CAPITAL MANAGEMENT#6 · 3,927,892 sh | 3,927,892 | $85.9M | <0.01% | +2.8% |
| 7 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)#7 · 3,779,900 sh | 3,779,900 | $82.6M | 0.86% | 0.0% |
| 8 | Eversept Partners#8 · 2,798,210 sh | 2,798,210 | $61.2M | 3.17% | -3.0% |
| 9 | GEODE CAPITAL MANAGEMENT#9 · 2,584,136 sh | 2,584,136 | $56.5M | <0.01% | +19.8% |
| 10 | Hood River Capital Management#10 · 2,564,279 sh | 2,564,279 | $56.1M | 0.41% | +8.9% |
| 11 | KINGDON CAPITAL MANAGEMENT, L.L.C.#11 · 2,500,000 sh | 2,500,000 | $54.6M | 5.60% | 0.0% |
| 12 | FRANKLIN RESOURCES#12 · 2,286,499 sh | 2,286,499 | $50.0M | 0.01% | +6.3% |
| 13 | MILLENNIUM MANAGEMENT#13 · 2,053,960 sh | 2,053,960 | $44.9M | 0.02% | +929.4% |
| 14 | VANGUARD PORTFOLIO MANAGEMENT#14 · 1,921,796 sh | 1,921,796 | $42.0M | <0.01% | +10.6% |
| 15 | UBS Group AG#15 · 1,893,750 sh | 1,893,750 | $41.4M | <0.01% | +64.2% |
| 16 | Elmind Capital#16 · 1,855,000 sh | 1,855,000 | $40.6M | 10.19% | 0.0% |
| 17 | BNP Paribas Asset Management Holding S.A.#17 · 1,790,173 sh | 1,790,173 | $39.1M | 0.04% | +3.3% |
| 18 | Candriam S.C.A.#18 · 1,696,040 sh | 1,696,040 | $37.0M | 0.17% | +83.3% |
| 19 | Soleus Capital Management, L.P.#19 · 1,628,039 sh | 1,628,039 | $35.6M | 1.23% | -5.7% |
| 20 | TWO SIGMA INVESTMENTS#20 · 1,578,125 sh | 1,578,125 | $34.5M | 0.03% | -0.1% |
| 21 | ORBIMED ADVISORS#21 · 1,542,000 sh | 1,542,000 | $33.7M | 0.62% | +60.2% |
| 22 | Nuveen#22 · 1,364,575 sh | 1,364,575 | $29.8M | <0.01% | -8.7% |
| 23 | MPM BioImpact#23 · 1,333,523 sh | 1,333,523 | $29.2M | 1.78% | -0.5% |
| 24 | Aisling Capital Management#24 · 1,316,806 sh | 1,316,806 | $28.8M | 6.10% | 0.0% |
| 25 | Woodline Partners#25 · 1,250,760 sh | 1,250,760 | $27.3M | 0.08% | 0.0% |
| 26 | D. E. Shaw#26 · 1,239,954 sh | 1,239,954 | $27.1M | 0.01% | -22.6% |
| 27 | Catalio Capital Management#27 · 1,215,698 sh | 1,215,698 | $26.6M | 4.99% | +16.5% |
| 28 | SILVERARC CAPITAL MANAGEMENT#28 · 1,214,390 sh | 1,214,390 | $26.5M | 2.76% | +36.6% |
| 29 | Prosight Management#29 · 1,200,000 sh | 1,200,000 | $26.2M | 4.52% | +55.8% |
| 30 | Trails Edge Capital Partners#30 · 1,110,000 sh | 1,110,000 | $24.3M | 3.85% | +58.2% |
| 31 | ALGERT GLOBAL#31 · 1,051,465 sh | 1,051,465 | $23.0M | 0.27% | +13.2% |
| 32 | Bank of New York Mellon#32 · 1,040,079 sh | 1,040,079 | $22.7M | <0.01% | +3.5% |
| 33 | SPHERA FUNDS MANAGEMENT LTD.#33 · 1,014,606 sh | 1,014,606 | $22.2M | 2.89% | +40.0% |
| 34 | LOOMIS SAYLES & L P#34 · 923,624 sh | 923,624 | $20.2M | 0.03% | New |
| 35 | Parkman Healthcare Partners#35 · 877,256 sh | 877,256 | $19.2M | 1.96% | -2.7% |
| 36 | Ensign Peak Advisors#36 · 867,831 sh | 867,831 | $19.0M | 0.03% | -12.4% |
| 37 | Palo Alto Investors#37 · 864,986 sh | 864,986 | $18.9M | 2.61% | 0.0% |
| 38 | AQR CAPITAL MANAGEMENT#38 · 853,304 sh | 853,304 | $18.7M | <0.01% | -13.0% |
| 39 | NORTHERN#39 · 845,537 sh | 845,537 | $18.5M | <0.01% | +11.9% |
| 40 | CHARLES SCHWAB INVESTMENT MANAGEMENT#40 · 814,303 sh | 814,303 | $17.8M | <0.01% | +13.9% |
| 41 | VANGUARD FIDUCIARY#41 · 633,509 sh | 633,509 | $13.8M | <0.01% | +5.5% |
| 42 | MORGAN STANLEY#42 · 588,979 sh | 588,979 | $12.9M | <0.01% | -34.1% |
| 43 | Rhenman & Partners Asset Management AB#43 · 560,250 sh | 560,250 | $12.2M | 1.16% | +47.7% |
| 44 | APIS CAPITAL ADVISORS#44 · 556,000 sh | 556,000 | $12.2M | 1.18% | +1.1% |
| 45 | PANAGORA ASSET MANAGEMENT#45 · 546,517 sh | 546,517 | $11.9M | 0.04% | +119.1% |
| 46 | Qube Research & Technologies Ltd#46 · 477,182 sh | 477,182 | $10.4M | <0.01% | +1223.8% |
| 47 | FIRST ADVISORS#47 · 456,700 sh | 456,700 | $10.0M | <0.01% | New |
| 48 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#48 · 454,101 sh | 454,101 | $9.9M | <0.01% | +131.0% |
| 49 | Granahan Investment Management#49 · 446,988 sh | 446,988 | $9.8M | 0.35% | +45.9% |
| 50 | Knott David M Jr#50 · 437,245 sh | 437,245 | $9.6M | 5.05% | +3.6% |
| 51 | Jump Financial#51 · 402,846 sh | 402,846 | $8.8M | 0.07% | New |
| 52 | abrdn plc#52 · 372,766 sh | 372,766 | $8.1M | 0.01% | +29.9% |
| 53 | Squarepoint Ops#53 · 370,317 sh | 370,317 | $8.1M | <0.01% | +104.0% |
| 54 | JUPITER ASSET MANAGEMENT LTD#54 · 366,568 sh | 366,568 | $8.0M | 0.04% | New |
| 55 | HRT FINANCIAL#55 · 363,147 sh | 363,147 | $7.9M | 0.02% | +308.5% |
| 56 | AMERIPRISE FINANCIAL#56 · 346,852 sh | 346,852 | $7.6M | <0.01% | +22.0% |
| 57 | Hennion & Walsh Asset Management#57 · 342,883 sh | 342,883 | $7.5M | — | +59.6% |
| 58 | Jones Hill Capital#58 · 340,000 sh | 340,000 | $7.4M | 1.58% | New |
| 59 | DAFNA Capital Management#59 · 335,255 sh | 335,255 | $7.3M | 1.40% | +54.2% |
| 60 | ENVESTNET ASSET MANAGEMENT#60 · 327,617 sh | 327,617 | $7.2M | <0.01% | +682.4% |
| 61 | RENAISSANCE TECHNOLOGIES#61 · 321,600 sh | 321,600 | $7.0M | <0.01% | -35.4% |
| 62 | Brevan Howard Capital Management#62 · 309,065 sh | 309,065 | $6.8M | 0.05% | +50.9% |
| 63 | Alyeska Investment Group, L.P.#63 · 308,507 sh | 308,507 | $6.7M | 0.02% | New |
| 64 | Verition Fund Management#64 · 304,939 sh | 304,939 | $6.7M | <0.01% | New |
| 65 | MACKENZIE FINANCIAL#65 · 280,079 sh | 280,079 | $6.1M | <0.01% | New |
| 66 | CITADEL ADVISORS#66 · 258,278 sh | 258,278 | $5.6M | <0.01% | -59.1% |
| 67 | Trexquant Investment#67 · 255,949 sh | 255,949 | $5.6M | 0.03% | +26.8% |
| 68 | SECTOR GAMMA AS#68 · 241,739 sh | 241,739 | $5.3M | 1.15% | -15.5% |
| 69 | Schonfeld Strategic Advisors#69 · 236,717 sh | 236,717 | $5.2M | 0.02% | -9.2% |
| 70 | JPMORGAN CHASE#70 · 231,446 sh | 231,446 | $5.1M | <0.01% | -10.5% |
| 71 | Pinnacle Financial Partners#71 · 217,173 sh | 217,173 | $4.7M | 0.03% | +7.4% |
| 72 | Man Group plc#72 · 213,703 sh | 213,703 | $4.7M | <0.01% | +17.4% |
| 73 | Y-Intercept (Hong Kong) Ltd#73 · 212,713 sh | 212,713 | $4.6M | — | New |
| 74 | HEALTHCARE OF ONTARIO PENSION PLAN FUND#74 · 207,250 sh | 207,250 | $4.5M | <0.01% | -37.5% |
| 75 | Pictet Asset Management Holding SA#75 · 207,936 sh | 207,936 | $4.5M | <0.01% | +1582.9% |
| 76 | Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insuran#76 · 200,000 sh | 200,000 | $4.4M | 1.15% | 0.0% |
| 77 | CITIGROUP#77 · 195,703 sh | 195,703 | $4.3M | <0.01% | +862.5% |
| 78 | SEI INVESTMENTS#78 · 193,134 sh | 193,134 | $4.2M | <0.01% | -11.2% |
| 79 | NOMURA ASSET MANAGEMENT INTERNATIONAL#79 · 180,000 sh | 180,000 | $3.9M | <0.01% | 0.0% |
| 80 | Swiss National Bank#80 · 168,100 sh | 168,100 | $3.7M | <0.01% | +4.2% |
| 81 | Atom Investors#81 · 162,524 sh | 162,524 | $3.6M | 0.32% | +4.2% |
| 82 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#82 · 161,323 sh | 161,323 | $3.5M | <0.01% | +7.7% |
| 83 | SummitTX Capital, L.P.#83 · 140,797 sh | 140,797 | $3.1M | 0.08% | +112.2% |
| 84 | Invesco Ltd.#84 · 138,060 sh | 138,060 | $3.0M | <0.01% | -45.4% |
| 85 | Russell Investments Group, Ltd.#85 · 135,012 sh | 135,012 | $3.0M | <0.01% | +33.0% |
| 86 | TORRAY#86 · 133,835 sh | 133,835 | $2.9M | 0.39% | +27.6% |
| 87 | RHUMBLINE ADVISERS#87 · 132,358 sh | 132,358 | $2.9M | <0.01% | +15.3% |
| 88 | WELLS FARGO & COMPANY#88 · 130,054 sh | 130,054 | $2.8M | <0.01% | +61.8% |
| 89 | PRICE T ROWE ASSOCIATES#89 · 128,199 sh | 128,199 | $2.8M | <0.01% | +19.7% |
| 90 | Pale Fire Capital SE#90 · 125,550 sh | 125,550 | $2.7M | 0.19% | -55.9% |
| 91 | CAPITAL FUND MANAGEMENT S.A.#91 · 125,091 sh | 125,091 | $2.7M | 0.01% | -14.1% |
| 92 | WELLINGTON MANAGEMENT GROUP LLP#92 · 124,241 sh | 124,241 | $2.7M | <0.01% | +0.5% |
| 93 | PFM Health Sciences#93 · 118,422 sh | 118,422 | $2.6M | 0.22% | -51.7% |
| 94 | SCHRODER INVESTMENT MANAGEMENT GROUP#94 · 115,208 sh | 115,208 | $2.5M | <0.01% | New |
| 95 | ALLIANCEBERNSTEIN L.P.#95 · 106,040 sh | 106,040 | $2.5M | <0.01% | -63.3% |
| 96 | Rafferty Asset Management#96 · 97,787 sh | 97,787 | $2.1M | <0.01% | -21.6% |
| 97 | DEUTSCHE BANK AG\#97 · 95,315 sh | 95,315 | $2.1M | <0.01% | +27.1% |
| 98 | HUSSMAN STRATEGIC ADVISORS#98 · 84,000 sh | 84,000 | $1.8M | 0.42% | New |
| 99 | Aquatic Capital Management#99 · 78,922 sh | 78,922 | $1.7M | 0.06% | +14.2% |
| 100 | WINTON GROUP Ltd#100 · 76,500 sh | 76,500 | $1.7M | 0.05% | +642.7% |
Funds that sold out of SNDX in Q2 2026 (39)
Held SNDX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.